← Back to Search

NAD+ Supplement

Qualia NAD+ for NAD+ Deficiency

N/A
Recruiting
Research Sponsored by Qualia Life Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy male and female participants between the ages of 40-65 years of age
Be older than 18 years old
Must not have
Having had a significant cardiovascular event in the past 6 months
Adults lacking capacity to consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This trial aims to see if Qualia NAD+ can raise NAD+ levels in the blood and if it is safe to use. Participants will either take Qualia NAD+ or a placebo

Who is the study for?
This trial is for individuals with NAD+ deficiency. Participants will take Qualia NAD+ or a placebo daily for 4 weeks and have their blood tested before and after the trial to measure NAD+ levels.
What is being tested?
The study aims to see if Qualia NAD+, compared to a placebo, can effectively raise NAD+ levels in the blood over a period of 4 weeks.
What are the potential side effects?
Since specific side effects are not provided, participants should be aware that they may experience unexpected reactions ranging from none to mild or more severe symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 40 and 65 years old and healthy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I had a major heart problem in the last 6 months.
Select...
I am unable to make my own medical decisions.
Select...
I am not pregnant, breastfeeding, nor planning to become pregnant during the trial.
Select...
I am currently taking medication for mental health or neurological conditions.
Select...
I am currently on medication to suppress my immune system.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Qualia NAD+Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Qualia Life SciencesLead Sponsor
~133 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top